Search

Author/Creator Olwill, Shane

1. Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein. Issue 2 (December 2015)

Authors:
Hinner, Marlon; Aiba, Rachida-Siham; Wiedenmann, Alexander; Schlosser, Corinna; Allersdorfer, Andrea; Matschiner, Gabriele; Rothe, Christine; Moebius, Ulrich; Kohrt, Holbrook; Olwill, Shane
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. O82 A phase 1 dose escalation study of PRS-343, a HER2/4–1BB bispecific molecule, in patients with HER2-positive malignancies. (15th April 2020)

Authors:
Piha-Paul, Sarina; Bendell, Johanna; Tolcher, Anthony; Hurvitz, Sara; Patnaik, Amita; Shroff, Rachna; Pohlmann, Paula; Zettl, Markus; Hahn, Noah; Krishnamurthy, Anuradha; Duerr, Manuela; Mei, Jian; Aviano, Kayti; Yusuf, Rushdia; Matis, Louis; Olwill, Shane; Bruns, Ingmar; Ku, Geoffrey
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 1
Page Start:
A1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search